Neurones shares have drifted over the past month, yet today’s earnings dropped a quiet challenge to that caution. The stock closed at €36.25 after a soft 30 day move, while the business posted H1 2026 revenue of €454.8m and trailing 12 month earnings from continuing operations of €66.3m. The real flashpoint is valuation. A P/E of 15.7x and a discounted cash flow estimate of €41.09 create a gap that traders appear to be testing against their nerves rather than the numbers.

Love that Neurones is printing solid earnings with a P/E below its own cash flow estimate signal, but uneasy about whether this gap is a value opportunity or a trap. Benchmark it against 181 high quality undervalued stocks to see how it stacks up against…